UKSPA News

Merit completes critical lateral flow test manufacturing facility for Abingdon Health

Offsite construction specialist, Merit, has successfully completed a contract to expand a Lateral Flow Test manufacturing facility for Abingdon Health in York, UK. 

The project was delivered by Merit’s specialist healthcare division, Merit Health, and is part of significant expansion plans for Abingdon Health, a leader in the field of rapid diagnostic development and manufacture.

Merit delivered a first class facility to further enhance Abingdon Health’s capabilities. Designed and built using next generation offsite construction techniques, the new facility was constructed with 39 Pre-Assembled Modules (PAMs). 75% of the build was manufactured offsite at Merit’s factory in Northumberland and then transported to York for assembly and installation by specialist installation teams.

The facility comprises highly technical spaces including wet laboratories that require close temperature control and dry room areas to a specification of 10% +/-5 relative humidity or less.

The new facility will support Abingdon Health’s ongoing development of high quality, effective rapid tests whilst enhancing their manufacturing capabilities and increasing output capacity.

Tony Wells, Managing Director at Merit, said:

“We enjoyed working collaboratively with Abingdon Health to deliver their new lateral flow manufacturing facility, which formed part of their exciting expansion plans. We manufactured a large part of the facility at the Merit factory, enabling Abingdon Health to continue their critical operations whilst we built their laboratory offsite. We achieved this by using our patent pending Pre-Assembled Modules (PAMs) system which was then transported to site for installation.

As well as minimising disruption, our offsite construction techniques offer fast track project delivery with improved quality, enhanced infection control and zero carbon emissions in operation.”

Oliver Gardner, Chief Operations Officer at Abingdon Health, said:

“We initiated our expansion strategy in 2019 to better serve the growing demand for rapid testing, which has been accelerated across all sectors due the exposure of lateral flow technology during the COVID-19 pandemic. The completion of this phase of expansion is critical for our plans going forward.

“Merit acted as a true partner, carrying out the build in and around our normal operations and minimising disruption for our R&D [research and development] and manufacturing teams.”

Member Related To This Article

Business rates must evolve with the changing shape of the UK’s economy

Learn More

The EpiCentre Innovation Director publishes AI search guide to help life science and biotech businesses gain global visibility

Learn More

The Crown Estate invests £1.5m into Greater Cambridge Impact and submits £2bn Cambridge Business Park redevelopment plans

Learn More

UK’s next generation of food innovators showcased at Colworth Science Park

Learn More

The Oxford Science Park announces refurbishment of Northbrook House

Learn More

Subscribe to Our Newsletter to Keep Up to Date With the Latest UKSPA News

UKSPA
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.